BTA 0.00% 57.0¢ biota holdings limited

tamiflu japan results released

  1. 8,256 Posts.
    Okay

    Get ready for bumper LANI sales in Japan, if Tamiflu sales are anything to go on.

    Tamiflu has sold very well for Jan-Mar 2012

    Here's the Chugai (Japan licensee) breakdown including a comparison from the previous 6 months:

    Tamiflu "Ordinary Sales"
    Jul-Dec 2011
    1.3bn Yen

    Jan-Mar 2012
    7.5bn Yen

    (Apr 2012 = 1.8bn Yen)

    Tamiflu "Govt Stockpile Sales"
    Jul-Dec 2011
    2.8bn Yen

    Jan-Mar 2012
    0.4bn Yen

    (Apr 2012 = 0bn Yen)

    6 months to Dec 2011 total = 4.1bn Yen
    3 months to Mar 2012 total = 7.9bn Yen

    The quote from the Chugai report was "Tamiflu: sales almost doubled reflecting a large flu season"

    So we have Daiichi Sankyo Inavir results due in a week and everything points to something very exciting and possibly a milestone bonus!

    By the way, has anyone manage to corner DL on the lack of GSK Relenza sales data breakdown in their recent quarterly? I would have been very interested to see the Japan data. The lack of published data stinks to high heaven.
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.